0001806540-21-000003.txt : 20210916 0001806540-21-000003.hdr.sgml : 20210916 20210915211023 ACCESSION NUMBER: 0001806540-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210916 DATE AS OF CHANGE: 20210915 EFFECTIVENESS DATE: 20210916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lycia Therapeutics, Inc. CENTRAL INDEX KEY: 0001806540 IRS NUMBER: 843860514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-413559 FILM NUMBER: 211256763 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 92121 BUSINESS PHONE: (650) 686-8821 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001806540 Lycia Therapeutics, Inc. 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 (650) 686-8821 DELAWARE None None Corporation true 2019 William Rieflin 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Clare Ozawa 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Thomas Woiwode 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Laurent Fischer 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Tim Anderson 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Aetna Wun Trombley 681 Gateway Blvd. 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-09-02 false true false 0 70055062 70055062 0 false 11 0 0 0 false Lycia Therapeutics, Inc. Aetna Wun Trombley Aetna Wun Trombley Chief Executive Officer 2021-09-15